REGENXBIO Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2017 | $11.2M | $224.1M | $82.0M |
| Jun 2017 | $12.7M | $224.4M | $57.6M |
| Sep 2017 | $14.6M | $209.3M | $59.9M |
| Dec 2017 | $15.6M | $198.7M | $46.7M |
| Mar 2018 | $17.9M | $317.2M | $71.9M |
| Jun 2018 | $18.8M | $336.0M | $106.9M |
| Sep 2018 | $20.9M | $515.0M | $142.4M |
| Dec 2018 | $35.0M | $543.8M | $75.6M |
| Mar 2019 | $32.0M | $519.0M | $55.9M |
| Jun 2019 | $34.5M | $529.1M | $55.1M |
| Sep 2019 | $40.8M | $509.2M | $79.6M |
| Dec 2019 | $47.7M | $497.9M | $69.5M |
| Mar 2020 | $43.8M | $463.9M | $69.4M |
| Jun 2020 | $51.9M | $449.7M | $94.2M |
| Sep 2020 | $125.5M | $541.2M | $93.2M |
| Dec 2020 | $330.4M | $708.2M | $338.4M |
| Mar 2021 | $324.9M | $879.4M | $291.5M |
| Jun 2021 | $329.2M | $836.4M | $257.1M |
| Sep 2021 | $339.0M | $800.4M | $228.4M |
| Dec 2021 | $349.6M | $1.11B | $345.2M |
| Mar 2022 | $335.7M | $1.03B | $191.9M |
| Jun 2022 | $322.9M | $953.4M | $121.4M |
| Sep 2022 | $320.0M | $883.8M | $118.5M |
| Dec 2022 | $317.1M | $833.3M | $97.0M |
| Mar 2023 | $282.7M | $747.8M | $70.1M |
| Jun 2023 | $276.6M | $682.5M | $68.6M |
| Sep 2023 | $270.7M | $633.8M | $53.0M |
| Dec 2023 | $262.2M | $574.0M | $34.5M |
| Mar 2024 | $238.5M | $629.2M | $113.0M |
| Jun 2024 | $221.1M | $569.4M | $57.8M |
| Sep 2024 | $217.7M | $519.1M | $56.6M |
| Dec 2024 | $206.3M | $466.0M | $57.5M |
| Mar 2025 | $216.7M | $490.9M | $130.1M |
| Jun 2025 | $367.3M | $581.0M | $79.6M |
| Sep 2025 | $363.8M | $525.2M | $58.8M |
| Dec 2025 | $350.3M | $453.0M | $34.5M |
| Mar 2026 | $320.8M | $341.9M | $15.2M |
| Jun 2026 | $314.9M | $386.6M | $36.5M |